(Q44700975)

English

Incidence of outpatient physician claims for upper gastrointestinal symptoms among new users of celecoxib, ibuprofen, and naproxen in an insured population in the United States

scientific article published in December 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Incidence of outpatient physician claims for upper gastrointestinal symptoms among new users of celecoxib, ibuprofen, and naproxen in an insured population in the United States (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1 reference

based on heuristic

inferred from title

author name string

Jay L Goldstein

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Sean Z Zhao

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Thomas A Burke

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Ryan Palmer

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Heather von Allmen

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Scott C Henderson

6

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

language of work or name

0 references

publication date

1 December 2003

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

98

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

2627-2634

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.08722.X

21 January 2018

Dyspepsia: how should we measure it?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.08722.X

21 January 2018

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.08722.X

21 January 2018

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.08722.X

21 January 2018

Dyspepsia tolerability from the patients' perspective: a comparison of celecoxib with diclofenac

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.08722.X

21 January 2018

Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.08722.X

21 January 2018

Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.08722.X

21 January 2018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.08722.X

21 January 2018

Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.08722.X

21 January 2018

Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.08722.X

21 January 2018

Efficacy and safety of the COX-2 specific inhibitor valdecoxib in the management of osteoarthritis of the hip: a randomized, double-blind, placebo-controlled comparison with naproxen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.08722.X

21 January 2018

Do NSAIDs cause dyspepsia? A meta-analysis evaluating alternative dyspepsia definitions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.08722.X

21 January 2018

Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.08722.X

21 January 2018

Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.08722.X

21 January 2018

The iatrogenic costs of NSAID therapy: a population study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.08722.X

21 January 2018

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.08722.X

21 January 2018

A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis. Rofecoxib/Ibuprofen Comparator Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2003.08722.X

21 January 2018

Identifiers

10.1111/J.1572-0241.2003.08722.X

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44700975&oldid=2032875372"